GSK (LSE:GSK) Capital Expenditure: £-2,980.00 Mil (TTM As of Mar. 2026)


LSE:GSK GSK PLC LSE:GSK
82 GF Score
Price £19.58
GF Value £16.51
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is GSK Capital Expenditure?

GSK LSE:GSK +1.71% 82 Capital Expenditure is £-2,980.00 Mil as of Mar. 2026. GuruFocus rates LSE:GSK with a GF Score™ of 82/100 and a GF Value™ of £16.51 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

GSK's cash flow for capital expenditures for the three months ended in Mar. 2026 was £-443 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2026 was £-2,980.00 Mil.

GSK Capital Expenditure Historical Data

* Premium members only.

The historical data trend for GSK's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK Capital Expenditure Chart

GSK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,654.00 -2,258.00 -2,344.00 -2,982.00 -2,985.00

GSK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -448.00 -633.00 -879.00 -1,025.00 -443.00
LSE:GSK
82GF Score
GSK PLC LSE:GSK
Capital Expenditure is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GSK Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was £-2,980.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Capital Expenditure →
What does a Capital Expenditure of £-2,980.00 Mil mean?
GSK (LSE:GSK) has a Capital Expenditure of £-2,980.00 Mil as of Mar. 2026. Capital Expenditures represent the company's purchases of property, plant, equipment and other long-term fixed assets. View historical data for GSK.
Is GSK's Capital Expenditure too high?
GSK's current Capital Expenditure is £-2,980.00 Mil. Overall, GSK has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does GSK's Capital Expenditure compare to LLY and JNJ?
GSK's Capital Expenditure of £-2,980.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capital Expenditure for a Drug Manufacturers company?
A good Capital Expenditure depends on the Drug Manufacturers industry context. However, Capital Expenditure should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capital Expenditure mean?
A high Capital Expenditure can signal that a stock is expensive relative to its fundamentals. Capital Expenditures represent the company's purchases of property, plant, equipment and other long-term fixed assets. View historical data for GSK. GSK's current Capital Expenditure is £-2,980.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
Based on GuruFocus' analysis, GSK (LSE:GSK) is currently considered Modestly Overvalued. The stock's GF Value™ is £16.51, compared to a current price of £19.58 — trading 18.6% above its estimated fair value. The current Capital Expenditure is £-2,980.00 Mil. GSK's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capital Expenditure calculated?
Capital Expenditure is calculated from a company's financial statements. For GSK (LSE:GSK), the current Capital Expenditure is £-2,980.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GSK (LSE:GSK) Overvalued in 2026?

Based on GuruFocus' analysis, GSK stock appears to be overvalued. The current stock price of £19.58 is trading 18.6% above its estimated GF Value™ of £16.51. GuruFocus considers GSK to be Modestly Overvalued.

Key valuation signals for LSE:GSK:

  • Capital Expenditure: £-2,980.00 Mil
  • GF Value™: £16.51 vs. price of £19.58 (18.6% above fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the LSE:GSK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GSK Business Description

Address 79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
82GF Score

Get the complete analysis for LSE:GSK

Capital Expenditure is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£19.58
Price
£16.51
GF Value